The main difference between a clinical trial and an expanded access program is that the intention of a clinical trial is to conduct research to test safety and efficacy of a new drug, while the intention of an expanded access program is for a physician to provide treatment to their patient with an unmet medical need. Both clinical trials and expanded access programs have eligibility criteria to determine who can participate.
However, the criteria of expanded access programs usually allow for a broader group of patients. This means that a patient who is not eligible for a clinical trial might be able to access a new drug via an expanded access program. Patients who enroll in expanded access programs are often the sickest patients who have exhausted other treatment options.
Dennis Akkaya
6 Oct 2026
11 mins read
Adrianne Rivard
25 Sep 2026
10 mins read
Laura Haggqvist
28 Aug 2026
15 mins read
Dennis Akkaya
21 Aug 2026
12 mins read
Madeleine Pagel
14 Aug 2026
14 mins read
Andrea Enguita
3 Aug 2026
18 mins read
Adrianne Rivard
14 Jul 2026
8 mins read
Theo Cantero
29 Jun 2026
10 mins read
myTomorrows Team
26 May 2026
4 mins read
Dennis Akkaya
26 May 2026
8 mins read